AEON Biopharma annual depreciation and amortization
2021
2022
2023
2024
2025
AEON Biopharma Depreciation & Amortization Growth & History (AEON)
AEON Biopharma's depreciation and amortization was $78,000 for fiscal 2025.
View full AEON Biopharma company overviewAEON Biopharma annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $78,000 | −$19,000 | −19.59% |
| 2024 | 2024-12-31 | $97,000 | $52,000 | +115.56% |
| 2023 | 2023-12-31 | $45,000 | −$23,000 | −33.82% |
| 2022 | 2022-12-31 | $68,000 | $65,000 | +2166.67% |
| 2021 | 2021-12-31 | $3,000 | — | — |
AEON Biopharma quarterly depreciation and amortization
Q1.23
Q2.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $20,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $19,000 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $20,000 | — | — |
| Q3 2025 | 2025-09-30 | $19,000 | −$6,000 | −24.00% |
| Q2 2025 | 2025-06-30 | $20,000 | −$4,000 | −16.67% |
| Q1 2025 | 2025-03-31 | $19,000 | −$6,000 | −24.00% |
| Q3 2024 | 2024-09-30 | $25,000 | $4,000 | +19.05% |
| Q2 2024 | 2024-06-30 | $24,000 | — | — |
| Q1 2024 | 2024-03-31 | $25,000 | $0 | 0.00% |
| Q3 2023 | 2023-09-30 | $21,000 | — | — |
| Q2 2023 · Jul 21 | 2023-07-21 | $6,000 | — | — |
| Q2 2023 · Jun 30 | 2023-06-30 | $23,000 | — | — |
| Q1 2023 | 2023-03-31 | $25,000 | — | — |
AEON Biopharma depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, AEON Biopharma's depreciation and amortization increased from $3,000 to $78,000, a change of $75,000. The latest reported quarter, Q2 2026, shows $20,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AEON Biopharma source filings ↗